ankinomycin6) and altromycins7). The FAB-MSspectra and the NMRstudies of the saptomycins indicated that saptomycins A, B, C1? C2, D, E, F, G and H were novel members of the family. In this paper, we describe the isolation, physico-chemical properties and structure elucidation of saptomycins A, B, Cl9 C2 and F from the parent strain and those of saptomycins D, E, G and H from the mutant.
Isolation
The isolation procedure from the cultured whole broth of the cultured Streptomyces sp. HP530 parent strain1* is shown in Fig. 1 . Saptomycins A, B, Cl9 C2 and F displayed lipophilic properties mainly associated with the mycelia. The mycelial cake was separated from 30 liters of the cultured broth by centrifuging and was then extracted with 5 liters of 80%acetone. The acetone extract was concentrated in vacuo to 500ml of aqueous solution. The residual solution was extracted with w-hexane (500 ml x 3) and then ethyl acetate (500ml x 3). The n-hexane extract (3.1 g) evaporated under reduced pressure was applied to a column packed with ODS-AQ120-S50 (Yamamura Kagaku: YMC), and saptomycins A and F were separately eluted with acetonitile - H2O(85 : 15) . Twoyellowish fractions were concentrated to dryness, yielding pure saptomycins A (24.0mg) and F (1 1.0 mg) as yellowish powders. On the other hand, the ethyl acetate extract was concentrated and dissolved in a small volume of methanol. The methanol solution was charged on the column shielded against light with ODS-AQ120-S50 and was then developed stepwise with a solvent system of 0.15% KH2PO4(pH 3.5)-methanol, 1 : 1 to 1 :4. Three yellowish active fractions, including OCT. 1993 saptomycins Cl9 C2 and B, respectively, were successively eluted, and then each fraction evaporated in vacuo was further purified by preparative TLC. Twofractions with saptomycins Ct and B were developed using the solvent system of chloroform-methanol (8 : 2, 1%NH4OH),respectively, and gave pure saptomycins C1 (15.7 mg) are B (3.4mg), while the fraction containing saptomycin C2 was developed with the same solvents using a 9 : 1 (1% NH4OH) ratio and yielded pure saptomycin C2 (10.6mg). Saptomycins D, E, G and H were isolated by a similar procedure from the mycelia cultured from the mutant strain. 7.5 g of the concentrated ethyl acetate extract from 45 liters of the fermentation broth was dissolved in a small volume of methanol and charged on the column packed with ODS-AQ120-S50. This mixture was further purified stepwise by chromatography using a solvent system of 0.15% KH2PO4-methanol,1 : 1 to 1 :4, and separated into three active fractions. Fraction 1 was separated by preparative TLC (chloroform-methanol, 100: 1, 1% NH4OH) to give saptomycins E (22.6mg) and H (3.5 mg) as yellow amorphous powders. Fractions 2 and 3 were also purified by preparative TLC, developed with the same solvent system using different ratios (chloroform-methanol, 99 : 1, 1% NH4OH and 95 : 5, 1% NH4OH), and yielded saptomycin D (36.1 mg) as a yellowish red powder and saptomycin G (2.1 mg) as a yellow powder, respectively.
Physico-chemical Properties
The physico-chemical properties of saptomycins A, B, Cl5 C2, D, E, F, G and H are summarized in Table 1 . These compounds were yellow needles, yellow powder or yellowish red powder. Saptomycins A and F were soluble in chloroform, methylene chloride and ethyl acetate, while saptomycins B, Cx and C2 Measured at 100MHz in (a) CDC13 or (b) C6D6; ppm from TMS. OCT. 1993 in the spectra of the other compounds. The *H and 13C NMRspectra data in chloroform-^or benzene-(i6 are summarized in Tables 2 and 3 .
Structure Elucidation The UV spectra of saptomycins A, B, C1? C2, D, E, F, G and H indicated the presence of a l l-hydroxy-4H-anthraceno[l ,2-b]pyran-4,7, 12-trione chromophore moiety in common,suggesting that the compounds were closely related to the pluramycin-group antibiotics2). The *H and 13C NMRspectral data (Tables 2 and 3 ) and other spectral data for each saptomycin, however, showed different characteristics from known pluramycin-group antibiotics.
Saptomycins A and F The HREI-MSdata of saptomycins A (as C24H20O6) and F (as C24H18O6) suggested the absence of the two aminosugar moieties at C-8 and C-10, which are well-knownin the pluramycin-group antibiotics. The 1H NMRspectra of saptomycins A and F, illustrating simple shapes, supported this suggestion. In the *H NMRof saptomycins A and F, characteristic signals were detected at 3-H (3 6.28 and 3 6.53), 6-H (3 8.09 and 3 8.08), 8-H ((57.83 and 3 7.82), 9-H (3 7.69 and 3 7.67), 10-H (3 7.36) and 13-H3 (3 3.02) in common. These properties are similar to those of a-indomycinone8), SF23309), SS43405D1O) and E11}, /Mndomycinone, rubiflavinone C-l and C-25) and hydramycin12). The side chains at C-2 of saptomycins A and F were, however, different from those of the knowncompounds without sugar moieties. The spectrum ofsaptomycin A indicated that the side chain of the compound was constituted of2 x CH3 groups (3 1.45 and 3 1.70), 2xolefin protons (3 5.50 and 3 5.65), 1 xO-CH group (35.01) and 1 XCH group (3 2.99). Examination of the 1H-1H COSYspectrum revealed the presence of a 2-hydroxy-l-methyl-3-pentenyl moiety at C-2, and the coupling constant for 17-H and 18-H was 10.5Hz, indicating the (Z)-configuration of an olefin system. This alkyl side chain had the same substructure as SS21020C13);
hence the comparison of 1H NMR spectra for both compoundssupported the commonstructure. In addition, the 13C NMRdata for the C-2 side chain described for SS21020C (3 130.4d; 3 125.6d; 3 68.8d; 344.9d; 3 13.3q; 3 12.7q) was identical to those ofsaptomycin A (<5 130.1d; 3 128.7d; 3 68.9d; 344.9d; (5 13.5q; <512.9q).
For determination of the structure of the side chain at C-2 of saptomycin F, the *H and 13C NMR spectral data were also available; therefore, structural elucidation was mainly based on these data.
Examination of the *H NMRand 1H-1H COSYspectra of saptomycin F suggested that the side chain was l,2-dihydroxy-l-methyl-3-pentenyl moiety or a l,2-epoxy-l-methyl-3-pentenyl moiety with a (Z)-configuration (/17fl8=11.0Hz).
The chemical shifts at 16-H in the *H and 13C NMRdata (3H 4.24/(5c 61.4) were obviously different from that of the 14,16-dihydroxyl compound PD121,22214) (3H 4.86/(5c 71.7) but identical to those of the 14,16-epoxy compound saptomycin D15) and pluramycin A2) (3H 4.06/(5c 61.6 and 3H 4. 15/3C 61.7, respectively).
The structures of saptomycins A and F were determined to be l l-hydroxy-5-methyl-2-(2-hydroxy-l-methyl-3-(Z)-pentenyl)-4H-anthraceno[l ,2-b]pyran-4,7, 1 2-trione and l l-hydroxy-5-methyl-2-(l,2-epoxy-l-methyl-3-(Z)-pentenyl)-4H-anthraceno[l ,2-b]pyran-4,7, 12-trione, respectively (Fig. 2) .
Saptomycins B, Cx and C2
The HRFAB-MSdata of saptomycins B, Cx and C2 indicated C41H52N2O9, C41H52N2O9 and Further, the 13C NMRspectra of saptomycins B, Cx and C2 indicated 41, 41, and 43 carbons, including in common 6 x C-CH3, 4 x N-CH3, 3 x methylenes, 8 xmethines, 5 x-CH=, ll x C=, 3 x OOand 1 x quaternary carbon (total 41 carbons), and that of saptomycin C2 showed two additional resonances from acetate (C-CH3and OO). These results showed that the structures of these three compounds wereclosely related.
The XH NMR spectra of saptomycins B, Ct and C2 are shown in Figs. 3~5. The spectrum of saptomycin Q (Fig. 3) was very similar to those of kidamycin4), hedamycin16), and rubiflavins5) with the exception of the signals due to the side chain moiety. On the other hand, the proton resonances for saptomycin B (Fig. 4) correspond very closely to that of isokidamycin4), which was the conflgurational isomer at C-6' of kidamycin, with the exception of resonances from the C-2 side chain. The *H NMR data for saptomycin C2 (Fig. 5 ) also showed that the compoundwas the C-2 side chain analog of pluramycin A and neopluramycin2). The three types of compounds described above were distiguishable in terms of the structural difference of each iV,7V-dimethylvancosamine moiety. In addition, the 59 (19-H3) . The coupling constant between the proton at 52.53 (16-HJ and at 3 2.70 (16-Hb) was 14.2Hz, indicating geminal protons. The result of the experiment proved the l-methyl-3-pentenyl constitution of the side chain from C-14 to C-19. The coupling constant between the olefinic protons of 17-H and 18-H was, however, not measured exactly because the former was overlapped with the proton at C-6' of the 7V,./V-dimethylvancosamine ring (Fig. 3) . In contrast, the *H NMRof saptomycin B indicated two isolated vinyl protons at 3 5.42 (17-H) and 3 5.58 (18-H), and the coupling constant between these two protons was 10.9 Hz, pointing to the (Z)-configuration (Fig. 4) ; hence the structure of the side chain at C-2 was determined as shown in Fig. 6 .
The UV spectra of saptomycins B, C^and C2 were similar to those of saptomycins A and F, characterizing the chromophore of these compoundsas an 1 l -hydroxy-4H-anthraceno[l ,2-b]pyran-4,7, 1 2-trione system, which is well-known as the chromophore of pluramycin group compounds. The *H NMR spectra of saptomycins B, Cx and C2 confirmed this suggestion by the three characteristic signals at 3 6.27, 36.25 and 3 6.24 (3-H), 3 7.99, 5 7.96 and 3 7.96 (6-H) and 3 8.43, 3 8.31 and 3 8.25 (9-H). This behavior suggested that two aminosugars were substituted at C-8 and C-10 in such a way as the previously described pluramycins carried two C-glycosidically bound aminosugars at C-8 and C-10. The aminosugar ring attached to C-8, angolosamine, of saptomycins B, Ci and C2 showed similar behavior in the 1H and 13C NMRspectra (Figs. 3~5 and Table 3 ). This ring was investigated in detail in the case of hedamycin16). The identity of conformation and configuration of the aminosugar moiety was established by comparison of the chemical shifts assigned in the *H and 13C NMRdata (Tables 2  and 3 ) and the 1H-1H coupling constants, except for a small number of overlapped signals. As previously described, another aminosugar ring, 7V,Af-dimethylvancosamine, was recognized to be of a different form in the cases of saptomycins B, Cx and C2, respectively, by the NMRstudies of these compounds. In particular, in the *H NMRspectra (Fig. 3~5 ), the sugar moiety possessed different coupling constants between 5'-Ha, 5'-Hb and 6'-H and between 2'-H and 3'-H (/r_3,=1.0Hz, /5,a_6,=11.5Hz, /5b_6>=3.0Hz for saptomycin B; /2 _3,<l.OHz, /5,a_6,=6.7Hz, /5b_6 =3.1Hz for saptomycin Cx; /2'-3'=4.5Hz, /5,a_6,=8.7Hz, /5,b_6,=3.1 Hz for saptomycin C2, shown in Fig. 7 ). In our previous papers15'17), we reported that the acetylation at the 3'-OH of saptomycin D caused a conformational change in the N,N-dimethylvancosamine ring. The different coupling constants between saptomycins Cl and C2 suggested that this conformational change had occurred. Further, deacetylation at 3'-OAc of saptomycin C2 in methanol at room temperature for 48 hours yielded saptomycin Cl5 proving that the observation was correct. It was proven that saptomycin B was a configurational isomer at the C-6' of saptomycin Cx from the detailed comparison of *H and 1 3C NMRdata with those of isokidamycih (Tables  2 and 3 ). The 1H NMRdata of kidamycin and isokidamycin40 clearly showed the different values of chemical shifts at 6'-H, 4'-CH3 and 2'-H of the N,Af-dimethylvancosamine moiety (3 5.40, 3 0.77 and 3 4.07 in kidamycin and 3 4.83, 3 1.21 and 3 3.83 in isokidamycin, respectively), while those of saptomycins C± and B were observed the similar results in the case ofkidamycin and isokidamycin (3 5.43, 3 0.72 and 3 4.04 in saptomycin Cx and <54.95, 3 1.23 and^3.87 in saptomycin B, respectively).
In the 13C NMRspectra of kidamycin and isokidamycin16), the chemical shifts at C-6', 4'-CH3 and C-5' gave the characteristic values depending of the configurational distinction (3 69.5, 3 12.3 and 3 33.6 in kidamycin and 3 72.3, 10.9 and (3 37.0 in isokidamycin, respectively) . Saptomycins Cx and B also revealed the characteristic values of the chemical shifts at C-6', 4'-CH3 and C-5' in the 13C NMRspectra (3 69.9, 3 12.2 and 3 33.1 in saptomycin C1 and 3 72.5, 3 1 1.0 and 3 36.9 in saptomycin B, respectively). The structures ofsaptomycins B, Cx and C2 were elucidated as shown in Fig. 2. Saptomycins D, E, G and H The molecular formulae of saptomycins D, E, G and H were determined to be C35H37NO9, C33H35NO9, C33H35NO8and C33H35NO9, respectively, according to the data of the HRFAB-MS spectra. These profiles suggested that saptomycins D, E, G and H were mono-C-aminoglycosyl compounds as is ankinomycin6). As previously reported15), the structural characteristics of saptomycins D and E were supported by the XHand 13C NMRspectra studies. A characteristic AB type spin system 8-H and 9-H (/8_9=7.9Hz) in the *H NMRand the chemical shift at C-8 (3 119.4) in the 13C NMRindicated the common structure of saptomycins D and E, lacking the angolosamine substituent at C-8 of typical pluramycin-group compounds. The other signals in the *H and 13C NMRspectra from the chromophore were also assigned on the basis of the results of^^H COSY,^C-1!! HETCOR and long range 13C-lU HETCOR experiments (Tables 2 and 3 ). In addition, these experiments showed the structures of the side chains at C-2 ofsaptomycins D and E to be a l ,2-epoxy-l-methyl-3-pentenyl moiety with a (Z)-configuration and a 1,2-epoxy-l-methylpropyl moiety, respectively. The corresponding resonances in the 1H and 13C NMRspectra of the side chains at C-2 in pluramycin A and epoxykidamycin18) supported the partial structures in saptomycins D and E. The configuration of the epoxides of both compoundswas determined to have cis geometry by the 3C value (3 14.4 and 3 13.6) of the methyl group at C-15: cis geometry such as in pluramycin A, hedamycin and ankinomycin had a value of ca. 14ppm, while trans geometry indicated a value ofca. 19 ppmin the case ofaltromycins7). Therefore, the relative configurations at C-2 in saptomycins D and E were determine to be (14i?*,16S*,17Z) and (14i?*,16S*), respectively. The 1H and 13C NMRspectra of saptomycin G showed a difference only in the side chain at C-2 from saptomycins D and E. The side chain in saptomycin G was composedof four varbon units: a quaternary carbon (C-14, 3C 126.4), two CH3 carbons (C-15, 3C ll.7; 3H 1.52s, C-17, 3C 14.5; 3H 1.57d) and a CH carbon (C-16, 3C 133.5; 3H 7.38q) . The values of the chemical shifts and coupling constants of the side chain at C-2 were nearly identical to those of the resonances in kidamycin and neopluramycin2'4). As a result, the structure of the substituent was determined to be a 1-methyl-1-propenyl group with an (is)-configuration, as confirmed by the observation of an NOEbetween C-15 and C-17 in the NOESY experiment. Saptomycins D, E and G carried a C-glycosidically bound 3'-0-acetyl-A^AT-dimethylvancosamine moiety at C-10 as pluramycin A and neopluramycin did, supported by the comparison of their *H and 13C NMRdata. The conformation of the aminosugar moiety was confirmed to be a chair form by comparison of the coupling constants between 5 -H and 6'-H (J5,a_6, = ca. 10.0 Hz and J5.h_6. = ca. 3.2Hz) and 2'-H and 3 -H (Jv_v=ca. 5.2Hz). As a result of all the experiments, the relative structures of saptomycins D, E and G were determined to be as shown in Fig. 2 .
Saptomycin
H appeared to be a configurational isomer at C-6' of the 3'-0-acetyl-J/V,7V-dimethyvancosamine moiety on saptomycin E, based on the *H and 13C NMRdata (Tables 2 and 3 ). The comparison of the values of the chemical shift of 6'-H and the^^H coupling constants in the XH NMRof the sugar in saptomycin H with those of saptomycin B indicated that saptomycins B and H had acharacteristicconfigurationincommon (56,_H=4.95, Jr-y = 1.0 Hz, /5,a_6, = 1 1.5 Hz andJ5,h_6, = 3.0 Hz in saptomycin B; (56,_H=5.14, /2 -3 <1-0Hz, /5,a_6,=10.6Hz and /5b_6,<2.0Hz in saptomycin H).
Further, saptomycin H displayed different NOESYdata from that of saptomycin E on their sugar moieties, summarized as Fig. 8 . Therefore, the structure of saptomycin H was determined as shown in Fig. 2 . The relative structure of the novel pluramycin-group antibiotics, saptomycins A, B, C1? C2, D, E, F, G and H were determined to be those of structure 1~9 based on analyses of all physico-chemical and spectroscopic studies (Fig. 2) . The absolute configuration of these compoundswere not determined, but it seemed that saptomycins were biologically related to other pluramycin-group antibiotics; hence we assumedthat the absolute configuration of saptomycins were the same as those of kidamycin19) and hedamycin20), previously studied in detail.
Experimental EI-MS and FAB-MSwere measured on a JEOLJMS-SX102spectrometer. IR spectra were recorded on a Hitachi 270-30 spectrometer. Optical rotations were taken on a Horiba SEPA-200 spectrometer. 1H and 13C NMRmeasurements were performed on a Varian VXR400spectrometer.
